153 related articles for article (PubMed ID: 15777989)
1. Serum anti-Yersinia antibody in Chinese patients with Kawasaki disease.
Chou CT; Chang JS; Ooi SE; Huo AP; Chang SJ; Chang HN; Tsai CY
Arch Med Res; 2005; 36(1):14-8. PubMed ID: 15777989
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Kawasaki disease showing elevated antibody titres of Yersinia pseudotuberculosis.
Tahara M; Baba K; Waki K; Arakaki Y
Acta Paediatr; 2006 Dec; 95(12):1661-4. PubMed ID: 17129979
[TBL] [Abstract][Full Text] [Related]
3. Cytopathogenic protein (CPP) produced by Propionibacterium acnes isolated from patients with Kawasaki disease.
Tomita S; Koga Y; Inoue O; Fujimoto T; Kato H
Prog Clin Biol Res; 1987; 250():73-80. PubMed ID: 3423083
[No Abstract] [Full Text] [Related]
4. Superantigens and Kawasaki disease.
Furukawa S; Matsubara T; Yabuta K
Immunol Today; 1991 Dec; 12(12):464. PubMed ID: 1786081
[No Abstract] [Full Text] [Related]
5. Is there an association between Kawasaki disease and Chlamydia pneumoniae?
Strigl S; Kutlin A; Roblin PM; Shulman S; Hammerschlag MR
J Infect Dis; 2000 Jun; 181(6):2103-5. PubMed ID: 10837204
[TBL] [Abstract][Full Text] [Related]
6. The pathogenesis of Kawasaki disease and superantigens.
Uchiyama T; Kato H
Jpn J Infect Dis; 1999 Aug; 52(4):141-5. PubMed ID: 10592892
[TBL] [Abstract][Full Text] [Related]
7. [Kawasaki disease: recent findings in etiology, pathogenesis and therapy].
Di Piero G; Bellisario G; Di Maggio M; Garibaldi G; Isola ML; Pauselli F; Proia R
Pediatr Med Chir; 1989; 11(2):209-17. PubMed ID: 2668907
[TBL] [Abstract][Full Text] [Related]
8. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. I. Occurrence of antibodies to Yersinia lipopolisacharydes and Yop proteins by ELISA].
Rastawicki W
Med Dosw Mikrobiol; 2006; 58(4):303-19. PubMed ID: 17642308
[TBL] [Abstract][Full Text] [Related]
9. Recurrent mucocutaneous lymph node syndrome (Kawasaki disease): a report of three cases.
Keren G; Passwell J; Cohen BE
J Med; 1986; 17(5-6):365-71. PubMed ID: 3473170
[TBL] [Abstract][Full Text] [Related]
10. Mantoux test in Kawasaki disease.
Bertotto A; Spinozzi F; Radicioni M; Vaccaro R
Pediatrics; 1996 Jul; 98(1):161. PubMed ID: 8668395
[No Abstract] [Full Text] [Related]
11. Brush border membrane antibodies in Yersinia infection and other diseases.
Montplaisir S; Gagné M; Dubois R; Gengoux P; Pelletier M
Contrib Microbiol Immunol; 1979; 5():351-8. PubMed ID: 394921
[No Abstract] [Full Text] [Related]
12. Spirochaetal studies in Kawasaki syndrome.
Marchette NJ; Melish ME; James JF; Kihara S; Caplan F
Prog Clin Biol Res; 1987; 250():87-99. PubMed ID: 3423085
[No Abstract] [Full Text] [Related]
13. A tetrapeptide shared by Yersinia outer membrane protein Yop1 and HLA-B27. Antibody response in patients with Yersinia-triggered reactive arthritis.
Lahesmaa R; Skurnik M; Granfors K; Möttönen T; Saario R; Toivanen A; Toivanen P
Scand J Rheumatol Suppl; 1990; 87():70-1. PubMed ID: 1701921
[No Abstract] [Full Text] [Related]
14. [Immunologic response to Yersinia antigens in patients with various rheumatic diseases].
Zaremba M; Karpińska B; Poniecki A; Bolińska J; Kacprzak-Wiater A; Czeczuga-Semeniuk E
Reumatologia; 1984; 22(1):35-45. PubMed ID: 6611570
[No Abstract] [Full Text] [Related]
15. Cross-antigenicity between Yersinia and Rickettsia.
Schlesinger M; Pollak S; Vardy PA
Isr J Med Sci; 1979 Jul; 15(7):612-3. PubMed ID: 582591
[No Abstract] [Full Text] [Related]
16. [Yersinia lipopolysaccharide and its biological activity].
Svarval' AV; Tseneva GIa; Shenderovich OA
Zh Mikrobiol Epidemiol Immunobiol; 2006; (3):100-4. PubMed ID: 16830602
[TBL] [Abstract][Full Text] [Related]
17. No increased seroprevalence of anti-Yersinia antibodies in patients with type 1 (C282Y/C282Y) hemochromatosis.
Jolivet-Gougeon A; Ingels A; Danic B; Aussant-Bertel F; Ferec C; Loréal O; Minet J; Brissot P
Scand J Gastroenterol; 2007 Nov; 42(11):1388-9. PubMed ID: 17852848
[No Abstract] [Full Text] [Related]
18. Serologic evidence that streptococcal superantigens are not involved in the pathogenesis of Kawasaki disease.
Morita A; Imada Y; Igarashi H; Yutsudo T
Microbiol Immunol; 1997; 41(11):895-900. PubMed ID: 9444333
[TBL] [Abstract][Full Text] [Related]
19. The role of bacterial lipopolysaccharide-bound neutrophils in the pathogenesis of Kawasaki disease.
Takeshita S; Nakatani K; Kawase H; Seki S; Yamamoto M; Sekine I; Yoshioka S
J Infect Dis; 1999 Feb; 179(2):508-12. PubMed ID: 9878040
[TBL] [Abstract][Full Text] [Related]
20. [Kawasaki mucocutaneous lymph node syndrome. 3 cases].
Estavoyer JM; Boichard D; Folschweiller B; Baufle GH; Debrand J; Perat R
Nouv Presse Med; 1979 Sep; 8(36):2908. PubMed ID: 493102
[No Abstract] [Full Text] [Related]
[Next] [New Search]
